WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 19, 2003, 23(33):10681-10690

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suh, S. W.
Right arrow Articles by Swanson, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suh, S. W.
Right arrow Articles by Swanson, R. A.

 Previous Article  |  Next Article 

Cellular/Molecular
Hypoglycemic Neuronal Death and Cognitive Impairment Are Prevented by Poly(ADP-Ribose) Polymerase Inhibitors Administered after Hypoglycemia

Sang Won Suh,1,3 Koji Aoyama,1,3 Yongmei Chen,1,3 Philippe Garnier,1,3 Yasuhiko Matsumori,2,3 Elizabeth Gum,1,3 Jialing Liu,2,3 and Raymond A. Swanson1,3

Departments of 1Neurology and 2Neurosurgery, University of California, San Francisco, California 94143, and 3Veterans Affairs Medical Center, San Francisco, California 94121

Severe hypoglycemia causes neuronal death and cognitive impairment. Evidence suggests that hypoglycemic neuronal death involves excitotoxicity and DNA damage. Poly(ADP-ribose) polymerase-1 (PARP-1) normally functions in DNA repair, but promotes cell death when extensively activated by DNA damage. Cortical neuron cultures were subjected to glucose deprivation to assess the role of PARP-1 in hypoglycemic neuronal death. PARP-1-/- neurons and wild-type, PARP-1+/+ neurons treated with the PARP inhibitor 3,4-dihydro-5-[4-(1-piperidinyl)butoxy]-1(2H)-isoquinolinone both showed increased resistance to glucose deprivation. A rat model of insulin-induced hypoglycemia was used to assess the therapeutic potential of PARP inhibitors after hypoglycemia. Rats subjected to severe hypoglycemia (30 min EEG isoelectricity) accumulated both nitrotyrosine and the PARP-1 product, poly(ADP-ribose), in vulnerable neurons. Treatment with PARP inhibitors immediately after hypoglycemia blocked production of poly(ADP-ribose) and reduced neuronal death by >80% in most brain regions examined. Increased neuronal survival was also achieved when PARP inhibitors were administered up to 2 hr after blood glucose correction. Behavioral and histological assessments performed 6 weeks after hypoglycemia confirmed a sustained salutary effect of PARP inhibition. These results suggest that PARP-1 activation is a major factor mediating hypoglycemic neuronal death and that PARP-1 inhibitors can rescue neurons that would otherwise die after severe hypoglycemia.

Key words: diabetes; glucose; glutamate; neuron; nitrotyrosine; water maze; 7-nitroindazole; 3-aminobenzamide


Received April 29, 2001; revised September 10, 2003; accepted September 26, 2003.




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. J. Bree, E. C. Puente, D. Daphna-Iken, and S. J. Fisher
Diabetes increases brain damage caused by severe hypoglycemia
Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E194 - E201.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Schmidt, M. Richter, D. Montag, T. Sartorius, V. Gawlik, A. M. Hennige, S. Scherneck, H. Himmelbauer, S. Z. Lutz, R. Augustin, et al.
Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1084 - E1094.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
T. M. Kauppinen, Y. Higashi, S. W. Suh, C. Escartin, K. Nagasawa, and R. A. Swanson
Zinc Triggers Microglial Activation
J. Neurosci., May 28, 2008; 28(22): 5827 - 5835.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. W. Suh, J. P. Bergher, C. M. Anderson, J. L. Treadway, K. Fosgerau, and R. A. Swanson
Astrocyte Glycogen Sustains Neuronal Activity during Hypoglycemia: Studies with the Glycogen Phosphorylase Inhibitor CP-316,819 ([R-R*,S*]-5-Chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide)
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 45 - 50.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. M. Hamby, S. W. Suh, T. M. Kauppinen, and R. A. Swanson
Use of a Poly(ADP-Ribose) Polymerase Inhibitor to Suppress Inflammation and Neuronal Death After Cerebral Ischemia-Reperfusion
Stroke, February 1, 2007; 38(2): 632 - 636.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. M. Kauppinen, W. Y. Chan, S. W. Suh, A. K. Wiggins, E. J. Huang, and R. A. Swanson
Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2
PNAS, May 2, 2006; 103(18): 7136 - 7141.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. W. Suh, K. Aoyama, Y. Matsumori, J. Liu, and R. A. Swanson
Pyruvate Administered After Severe Hypoglycemia Reduces Neuronal Death and Cognitive Impairment
Diabetes, May 1, 2005; 54(5): 1452 - 1458.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. M. Kauppinen and R. A. Swanson
Poly(ADP-Ribose) Polymerase-1 Promotes Microglial Activation, Proliferation, and Matrix Metalloproteinase-9-Mediated Neuron Death
J. Immunol., February 15, 2005; 174(4): 2288 - 2296.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. W. Suh, Y. Fan, S. M. Hong, Z. Liu, Y. Matsumori, P. R. Weinstein, R. A. Swanson, and J. Liu
Hypoglycemia Induces Transient Neurogenesis and Subsequent Progenitor Cell Loss in the Rat Hippocampus
Diabetes, February 1, 2005; 54(2): 500 - 509.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Iwashita, S. Yamazaki, K. Mihara, K. Hattori, H. Yamamoto, J. Ishida, N. Matsuoka, and S. Mutoh
Neuroprotective Effects of a Novel Poly(ADP-Ribose) Polymerase-1 Inhibitor, 2-{3-[4-(4-Chlorophenyl)-1-piperazinyl] propyl}-4(3H)-quinazolinone (FR255595), in an in Vitro Model of Cell Death and in Mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Model of Parkinson's Disease
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1067 - 1078.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-